Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantinescu

Showing results (71-80 of 2,282) with videos related to

Pageof 229
Sort By:
Cureus|February 12, 2024
Two Cases of Acute Diverticulitis Following Ocrelizumab Infusion in Patients With Multiple SclerosisNicholas Vigilante, Cris S Constantinescu
Inflammation & Allergy Drug Targets|October 5, 2010
The role of osteopontin in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS)Manjit Braitch, Cris S Constantinescu
JAK-STAT|September 24, 2013
The JAK-STAT pathway and hematopoietic stem cells from the JAK2 V617F perspectiveJudith Staerk, Stefan N Constantinescu
Hematology. American Society of Hematology. Education Program|November 24, 2005
A unique activating mutation in JAK2 (V617F) is at the origin of polycythemia vera and allows a new classification of myeloproliferative diseasesWilliam Vainchenker, Stefan N Constantinescu
Leukemia|December 7, 2017
Rethinking JAK2 inhibition: towards novel strategies of more specific and versatile Janus kinase inhibitionE Leroy, S N Constantinescu
Expert Opinion on Drug Metabolism & Toxicology|March 4, 2014
Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosisRadu Tanasescu, Cris S Constantinescu
Immunobiology|September 22, 2009
Cannabinoids and experimental models of multiple sclerosisIlona Kubajewska, Cris S Constantinescu
International Journal of Molecular Sciences|November 13, 2021
Anticancer Activity of Natural and Synthetic ChalconesTeodora Constantinescu, Claudiu N Lungu
Current Neurology and Neuroscience Reports|July 12, 2012
Cost-effectiveness of disease-modifying therapies in multiple sclerosisAli Manouchehrinia, Cris S Constantinescu
Analytical Biochemistry|August 1, 1985
A mixed hemagglutination test for binding of glycosylated cytochemical markersV Mureşan, M C Constantinescu
Pageof 229

Showing results (71-80 of 2,282) with videos related to

Sort By:
Pageof 229
Cureus|February 12, 2024
Two Cases of Acute Diverticulitis Following Ocrelizumab Infusion in Patients With Multiple SclerosisNicholas Vigilante, Cris S Constantinescu
Inflammation & Allergy Drug Targets|October 5, 2010
The role of osteopontin in experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS)Manjit Braitch, Cris S Constantinescu
JAK-STAT|September 24, 2013
The JAK-STAT pathway and hematopoietic stem cells from the JAK2 V617F perspectiveJudith Staerk, Stefan N Constantinescu
Hematology. American Society of Hematology. Education Program|November 24, 2005
A unique activating mutation in JAK2 (V617F) is at the origin of polycythemia vera and allows a new classification of myeloproliferative diseasesWilliam Vainchenker, Stefan N Constantinescu
Leukemia|December 7, 2017
Rethinking JAK2 inhibition: towards novel strategies of more specific and versatile Janus kinase inhibitionE Leroy, S N Constantinescu
Expert Opinion on Drug Metabolism & Toxicology|March 4, 2014
Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosisRadu Tanasescu, Cris S Constantinescu
Immunobiology|September 22, 2009
Cannabinoids and experimental models of multiple sclerosisIlona Kubajewska, Cris S Constantinescu
International Journal of Molecular Sciences|November 13, 2021
Anticancer Activity of Natural and Synthetic ChalconesTeodora Constantinescu, Claudiu N Lungu
Current Neurology and Neuroscience Reports|July 12, 2012
Cost-effectiveness of disease-modifying therapies in multiple sclerosisAli Manouchehrinia, Cris S Constantinescu
Analytical Biochemistry|August 1, 1985
A mixed hemagglutination test for binding of glycosylated cytochemical markersV Mureşan, M C Constantinescu
Pageof 229